DIALYSIS · CCN 312665

USRC Marlton

MARLTON, NJ 08053

DialysisProfitUS Renal Care, Inc.
$6.2M
TOTAL REVENUE
25.0%
OPERATING MARGIN
3 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.2M
Total costs
$4.7M
Operating income (rev − costs)
$1.5M
Operating margin
25.0%
Total charges
$6.2M
Total treatments
12,176
Dialysis stations
9

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9948—
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
8848—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.3974—
Fistula Rate
DFC_FISTULA_RATE
50.955—
Five Star Rating
DFC_FIVE_STAR
3——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
168.283—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
095—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.51——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1855—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
18.7260—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
51.568—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
2888—
Standardized ED Visits Ratio
DFC_SEDR
0.656—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
39.647—